PCSK9-IN-16
PCSK9-IN-16 is a potent PCSK9 inhibitor. PCSK9-IN-16 is extracted from patent WO2020150474, example 87, has the potential for hypercholesterolemia and other cardiovascular diseases research[1].
Product Specifications
CAS Number
2455424-51-6
UNSPSC
12352005
Target
PCSK9
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/pcsk9-in-16.html
Solubility
10 mM in DMSO
Smiles
CSC1=CN=C(N=C1)NC[C@H](C)CNC(SC2=C3)=NC2=CC=C3S(N)(=O)=O
Molecular Formula
C16H20N6O2S3
Molecular Weight
424.56
References & Citations
[1]Michael H, et al. Pcsk9 inhibitors and methods of use thereof. Patent WO2020150474
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC881486-100 1x 100 µL
DOG-1 / TMEM16A (Gastrointestinal Stromal Tumor Marker) (DG1/1486), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
